Apl Apollo Tubes
neutral mediumAPL Apollo reported a strong Q4 FY26 with 9% volume growth YoY and EBITDA per ton exceeding ₹5,500, driven by market leadership, product innovation, and steel shortages.
Read Apl Apollo Tubes analysis →Side-by-side earnings comparison across verified financials, AI summaries, management guidance, risks, quotes, and accountability signals.
APL Apollo reported a strong Q4 FY26 with 9% volume growth YoY and EBITDA per ton exceeding ₹5,500, driven by market leadership, product innovation, and steel shortages.
Read Apl Apollo Tubes analysis →SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion.
Read SRF analysis →APL Apollo reported a strong Q4 FY26 with 9% volume growth YoY and EBITDA per ton exceeding ₹5,500, driven by market leadership, product innovation, and steel shortages. Full-year operating cash flow was ₹20 billion and free cash flow ₹13 billion, with net cash of ₹15 billion+. However, the Middle East crisis, gas shortages, and steel price volatility disrupted operations, particularly in Dubai (40% utilization) and domestic galvanized lines. Management maintains FY27 guidance of 15-20% volume growth and 20-25% PAT growth, focusing on margin protection over volume. Risks include prolonged geopolitical disruption, energy shortages, and potential demand slowdown from construction site halts.
SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion. The chemicals business grew 16% to ₹7,779 crore, while performance films and technical textiles showed recovery. Management guided for 15-20% growth in chemicals in FY27, supported by HFC debottlenecking, specialty chemicals recovery, and new capacities (HFO, fluoropolymers, BOPP). Key risks include geopolitical disruptions in the Middle East, forex mark-to-market losses, and pricing pressure in specialty chemicals from Chinese competition.
Volume increased 9% year-over-year in Q4 FY26 despite disruptions.
EBITDA per ton exceeded ₹5,500, up from guided ₹5,000-5,500 range.
Net cash increased from ₹5.5 billion in Q3 to over ₹15 billion in Q4.
Market share improved from 55% to 60-65% in FY26, aided by disruption.
Debottlenecking investment of ₹88 crore to increase HFC capacity beyond 65,000 metric tons per annum.
New site in Odisha for 20,000 MTPA HFO capacity, backward integration, and electronic grade HF.
Capital and revenue R&D spend in FY26; 40 patents filed, cumulative 521 filed.
Aligned with long-term growth priorities including HFO, fluoropolymers, and pharma intermediates.
Management targets 15-20% volume growth for FY27, with a focus on margin protection.
Management guidance growthPAT growth target of 20-25% for FY27, supported by margin expansion.
Management guidance growthManagement expects EBITDA per ton to remain in the ₹5,000-5,500 range going forward.
Management guidance marginsTotal capex of ₹14,500 crore over next 2.5 years to reach 8 million tonnes capacity by FY28.
Management guidance capexManagement expects the chemicals segment to grow 15-20% in FY27, driven by HFC volumes, specialty recovery, and new capacities.
Management guidance revenueThe new HFO plant in Odisha is expected to be commissioned by February 2028, with all three products coming up in parallel.
Management guidance expansionThe new BOPP line is on track to start production in July 2026, strengthening the packaging films portfolio.
Management guidance expansionA state-of-the-art polyamide line, India's first based on simultaneous stretching, will be operational by September 2027 with an investment of ₹180 crore.
Management guidance expansionThe ongoing war has disrupted global supply chains and impacted Dubai operations at 40% utilization.
high · management_commentaryGas shortages caused temporary shutdowns in March; fear of recurrence may limit production to 80-85%.
high · management_commentaryConstruction sites halted due to labor shortages and raw material price inflation, delaying purchases.
medium · analyst_questionRapid steel price increases may lead to destocking; however, low inventory days mitigate mark-to-market risk.
medium · data_observationSales into the Middle East were impacted in Q4 due to geopolitical tensions, though management rerouted shipments to other markets.
medium · management_commentarySharp rupee depreciation led to mark-to-market losses on forward hedges, impacting FY26 results and expected to persist near-term.
medium · management_commentaryAggressive Chinese pricing has compressed margins in specialty chemicals; management expects normalization but timing uncertain.
high · analyst_questionGovernment has not clarified whether HCFC production will be included in baseline quota calculations, creating regulatory risk for HFC capacity expansion.
medium · analyst_questionOur focus right now is to protect our profitability and margins. When we know that volume prediction becomes challenging, because APL Apollo is the market leader, we are able to improve our margins significantly.
If you look at our market share in FY26 versus FY25, our market share has improved to 60-65% from 55%. This can continue to improve if disruption continues to hurt our competition more than the larger player like Apollo.
We believe that the company should be able to deliver growth in the region of 15 to 20% in the coming year.
Our ability to reposition has ensured that we stayed strong in terms of the outcome for Q4.